Review maps NSCLC-to-SCLC transformation amid expanding lung cancer treatments
A 2026 literature review synthesizes clinical, diagnostic, molecular and therapeutic evidence on transformation from non–small cell lung cancer to small ...
Tag: Treatment strategies
Osimertinib Resistance and EGFR Mutations in NSCLC Treatment
The presence of the T790M mutation during first or second-generation EGFR-TKI treatments is observed in 50-60% of patients. This mutation ...
POPULAR NEWS
-
Australian Stakeholders Largely Support Statutory Registration for Non-Registered Health Professions
-
Kalman Filter Improves Traction Force Microscopy Accuracy
-
Trimetallic Oxide Coating Yields Flexible Supercapacitor with 86% Retention
-
Recurrent Tongue Bleeding Treated in Woman With Hereditary Hemorrhagic Telangiectasia